1. Zhou, P., Goldstein, S., Devadas, K., Tewari, D., and Notkins, A.L. (1997). Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nature Med. 3:659.

2.Zhou, P., Goldstein, S., Devadas, K., Tewari, D., and Notkins, A.L. (1998). Cells transfected with a non-neutralizing antibody gene are resistant to HIV infection: targeting the endoplasmic reticulum and trans-Golgi network. J. Immunol. 160:1489-1496.

3.Tewari, D., Goldstein, S., Notkins, A.L., and Zhou, P. (1998). CDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication. J. Immunol. 161:2642-2647.

4.Zhou, P., Devedas, K., Tewari, D., Jegorow, A., and Notkins, A.L. (1999). Processing, secretion and anti-HIV-1 activity of IL-16 with or without a signal peptide in CD4+ T cells. J. Immunol. 163:906-912.

5.Zhou, P., Lee, J., Moore, P., and Brasky, K.M. (2001). High-Efficiency Gene Transfer into Rhesus Macaque Primary T Lymphocytes by Combining 32 degree C Centrifugation and CH-296-Coated Plates: Effect of Gene Transfer Protocol on T cell Homing Receptor Expression. Hum. Gene Ther. 12:1843-1855.

6.Tewari, D., Notkins, A.L., and Zhou, P. (2003). Inhibition of HIV-1 Replication in Primary Human T cells Transduced with an Intracellular Anti-HIV-1 p17 Antibody Gene. J. Gene Med. 5:182.

7.Lee S-J., Garza, L., Yao, J., Notkins, A.L., and Zhou, P.(2004). A non-neutralizing anti-HIV-1 antibody turns into a neutralizing antibody when expressed on the surface of HIV-1-susceptible cells: a new way to fight HIV. J. Immunol. 173:4618-4626.

8.Lee SJ, Arora R. Bull LM, Arduino RC, Garza L, Allan J, Kimata JT, Zhou, P. (2006). A non-neutralizing anti-HIV-1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV-1-susceptible cells (II): inhibition of HIV-1 captured and transferred by DC-SIGN. AIDS Res. and Hum. Retroviruses, 22:874

专利

Zhou P, Tsai CG, Toyada T, Buchy P Lentivirus pseudotyped with hemagglutinin and neuraminidase and methods of use. DI #06/66.